- Browse by Author
Browsing by Author "York, Nadya E."
Now showing 1 - 5 of 5
Results Per Page
Sort Options
Item Comprehensive Costs Associated with Fiberoptic and Digital Flexible Ureteroscopes at a High Volume Teaching Hospital(Elsevier, 2017-05) Borofsky, Michael S.; Dauw, Casey A.; York, Nadya E.; Hoovler, Christine; Lingeman, James E.; Urology, School of MedicineIntroduction Modern flexible ureteroscope ownership costs are considerable. Most prior estimates focus exclusively on repair costs, likely underestimating overall costs, including those of acquisition and reprocessing. Furthermore, to our knowledge no prior cost analyses focus on the latest generation digital flexible ureteroscope, which may differ due to unique purchase and repair prices. We sought to gain greater insight into the comprehensive costs associated with modern flexible ureteroscope use, particularly the difference between digital and fiberoptic models. Methods Data on use and repair of fiberoptic Storz Flex-X2 and digital Flex-Xc flexible ureteroscopes from 2011 to 2015 were reviewed. List prices and repair costs were obtained from Storz. Per case reprocessing costs were estimated, accounting for disposables, reagents and labor. Maintenance costs were estimated by combining cost of repairs and reprocessing. Analyses were performed at list pricing and standard discount rates. Global flexible ureteroscope costs were calculated to account for the cost of acquisition, repair and maintenance of a new scope during its first 100 uses. Results Global costs associated with digital flexible ureteroscope ownership were 1.3 to 1.4 times greater than fiberoptic on a per case basis ($1,008/$1,086 vs $715/$835). The majority of expenses went toward scope repairs (73% vs 71%), with instrument purchase (23% vs 24%) and reprocessing (4% vs 5%) being less costly. Repair rates were not significantly different between fiberoptic and digital devices (12.5 vs 11.5, p=0.757). Conclusions Expenditures associated with ownership of modern flexible ureteroscopes are considerable and driven primarily by the high cost of repairs. Digital instruments are more costly despite comparable rates of flexible ureteroscope damage.Item Randomized controlled trial comparing three different modalities of lithotrites for intracorporeal lithotripsy in pcnl(Liebert, 2017) York, Nadya E.; Borofsky, Michael S.; Chew, Ben H.; Dauw, Casey A.; Paterson, Ryan F.; Denstedt, John D.; Razvi, Hassan; Nadler, Robert B.; Humphreys, Mitchell R.; Preminger, Glenn M.; Nakada, Stephen Y.; Krambeck, Amy E.; Miller, Nicole L.; Terry, Colin; Rawlings, Lori D.; Lingeman, James E.; Department of Urology, School of MedicinePurpose: To compare the efficiency (stone fragmentation and removal time) and complications of three models of intracorporeal lithotripters in percutaneous nephrolithotomy (PCNL). Materials and Methods: Prospective, randomized controlled trial at nine centers in the North America from 2009 to 2016. Patients were randomized to one of three lithotripter devices: the Cyberwand, a dual probe ultrasonic device; the Swiss Lithoclast Select, a combination pneumatic and ultrasonic device; and the StoneBreaker, a portable pneumatic device powered by CO2 cartridges. Since the StoneBreaker lacks an ultrasonic component, it was used with the LUS‐II ultrasonic lithotripter to allow fair comparison with combination devices. Results: 270 patients were enrolled, 69 were excluded after randomization. 201 patients completed the study: 71 in the Cyberwand group, 66 in the Lithoclast Select, and 64 in the StoneBreaker group. The baseline patient characteristics of the three groups were similar. Mean stone surface area was smaller in the StoneBreaker group at 407.8mm2 vs 577.5mm2 (Lithoclast Select) and 627.9mm2 (Cyberwand). The stone clearance rate was slowest in the StoneBreaker group at 24.0 mm2/min vs 28.9 mm2/min and 32.3 mm2/min in the Lithoclast Select and Cyberwand groups respectively. After statistically adjusting for the smaller mean stone size in the StoneBreaker group, there was no difference in the stone clearance rate among the three groups (p=0.249). Secondary outcomes, including complications and stone free rates, were similar between the groups. Conclusions: The Cyberwand, Lithoclast Select, and the StoneBreaker lithotripters have similar adjusted stone clearance rates in PCNL for stones > 2cm. The safety and efficacy of these devices are comparable.Item Stone free outcomes of flexible ureteroscopy for renal calculi utilizing CT imaging(Elsevier, 2018) York, Nadya E.; Zheng, Mengmeng; Elmansy, Hazem M.; Rivera, Marcelino E.; Krambeck, Amy E.; Lingeman, James E.; Urology, School of MedicineObjectives To assess stone free rates following URS for renal calculi at our institution using low dose renal only CT (LDCT). Methods A retrospective review of patients undergoing flexible URS for renal stones only with subsequent CT scan within 3 months. Meticulous basketing of all stone fragments was performed whenever possible. A “true” zero fragment SFR was determined by reviewing the CT scan and radiologist's report. Patients with nephrocalcinosis (as determined by visual inspection of papilla at the time of URS) were assigned the “stone free” category. Results Flexible URS was performed in 288 renal units of 214 patients with renal calculi from 2013 to 2016. Median pre-operative stone size was 6.2mm with the average kidney containing 6.4 stones. An access sheath was used in 92% of cases. A total of 73% (209/288) renal units were completely stone free by CT assessment. Patients with residual fragments were as follows: 1mm in 2% (7/288), 2-4 mm in 16% (46/288), and >4 mm in 9% of kidneys (26/288). Conclusions The true stone free rate in patients undergoing flexible URS for renal calculi utilizing active basketing of fragments as determined by strict CT assessment was 73%. In patients with residual fragments, the majority are 2-4 mm in size making URS a treatment option for renal calculi with excellent stone free results.Item A Survey of Morcellator Preference and Cost Comparison of the Lumenis VersaCut and Wolf Piranha Morcellators(Elsevier, 2017) Rivera, Marcelino E.; Lingeman, James E.; Heinsimer, Kevin; York, Nadya E.; Krambeck, Amy E.; Urology, School of MedicineObjective To evaluate operating room (OR) costs associated with the 2 available morcellators in the United States in a matched cohort and to determine benign prostatic hyperplasia surgeon's morcellator preference. Materials and Methods Patients from 2013, the last year our institution exclusively used the VersaCut device, were matched 1:1 with the most recent patient cohort, utilizing the Wolf Piranha morcellator. Cost of morcellation including the expense of OR time and disposable instrument costs were calculated. A survey to the Endourological Society e-mail listserv was sent to determine morcellator preference. Results We identified 142 patients who underwent holmium laser enucleation of the prostate in 2013. When compared with the VersaCut group, morcellation efficiency (4.4 vs 7.0 g/min, P <.01) and expense of OR time ($1420.80 vs $992.21, P <.005) both favored the Piranha morcellator system even when the costs of disposable instruments were factored into the analysis ($1338.81 vs $1637.50, P <.05). A total of 126 urologists responded to the survey. Of these, 56 (44.5%) perform transurethral prostate enucleations, which included 48 (86%) holmium. More endourologists use the VersaCut (n = 33, 59%) than the Piranha (n = 24, 43%) morcellator. Qualities that impacted the preference of morcellator included the preferred device is safer, faster, easier to use, reusable, and less expensive. Conclusion We identified a significant improved efficiency and improved cost savings utilizing the Piranha morcellator even when controlling for disposable costs. Of the endourologists who responded to the survey, less than half perform transurethral enucleation. Morcellator preference is largely based on safety, efficiency, and ease of use, whereas cost and reusablility were of lesser importance.Item Variability in stone composition and metabolic correlation between kidneys in patients with bilateral nephrolithiasis(Elsevier, 2019-12-20) Rivera, Marcelino E.; Nottingham, Charles U.; Borofsky, Michael S.; Kissel, Suzanne M.; Maniar, Viraj; Dauw, Casey A.; York, Nadya E.; Krambeck, Amy E.; Lingeman, James E.; Urology, School of MedicineIntroduction: To evaluate the clinical significance of discordant stone analyses in patients undergoing bilateral ureteroscopy. Methods: A retrospective chart review was performed for all patients undergoing stone extraction with bilateral ureteroscopy at our institution in an aim to identify patients who had bilateral stone analysis and 24-hour urine chemistry data available. Stones were then classified based upon the dominant present (>50%). Twenty-four hour urinalysis results were reviewed and statistical analysis performed comparing discordant and concordant patient populations, assessing significant differences that would potentially influence clinical management. Results: We identified 79 patients (158 renal units) who had bilateral stones removed at the time of ureteroscopy. The majority of stones were classified as calcium oxalate (CaOx) (60.1%) followed by calcium phosphate (CaP) (27.8%), brushite (5.1%), uric acid (UA) (4.4%) and cystine (2.5%). Discrepancies in stone classifications were present 24% of the time. Evaluation of 24-hour urinalysis results demonstrated that patients with CaOx:CaP stone discordance compared to CaOx:CaOx concordant stone formers were more likely to have an elevated pH (p=0.02) and lower uric acid supersaturation (p=0.01). Conclusions: Discrepancies in stone mineral content are common in patients with bilateral stone disease. A single stone analysis from one side in the setting of bilateral stone disease is insufficient for management of patients with bilateral renal stones, and may lead to mismanagement when this misrepresented information is utilized in addition to 24-hour urinalysis results. At least one stone analysis should be performed from both sides during a bilateral stone extraction procedure.